CTRI/2018/04/012944已完成4 期
Clinical assessment of Glycopyrrolate in cOpd phenotypes, A drug utilizAtion surveilLance (GOAAL) study in outpatient settings of India - GOAA
Glenmark Pharmaceuticals Ltd0 个研究点目标入组 1,215 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,215
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. COPD patients with GOLD B/C status who were symptomatic with more than or equal to 1 moderate to severe exacerbation in
- •last six months that required antibiotics or short course oral corticosteroids
- •2. FEV1/FVC less than 0.7 with FVC less than 80%
排除标准
- •Patients with less than 1 follow up visit to be excluded
研究者
相似试验
已完成
4 期
A clinical study to understand the safety and efficacy of Glycopyrrolate in respiratory diseases.CTRI/2017/09/009845Glenmark Pharmaceuticals Ltd
已完成
4 期
Study on utilization of glycopyrronium and arformoterol inhalation as a treatment for COPD.CTRI/2019/07/020144Glenmark Pharmaceuticals Ltd49
尚未招募
不适用
Do children really require Glycopyrrolate injection before anaesthesia?CTRI/2018/08/015459Childrens Anaesthesia Services Mumbai
已完成
不适用
A clinical study on the effect of glycopyrrolate on the maternal blood pressure and vasopressor requirement during cesarean deliveryCTRI/2020/12/029495JSS Medical College and Hospital60
招募中
3 期
Clinical evaluation of the effect of Glycyrrhiza glabra root hydroalcoholic extract on the second degree burn wound healingBurn.IRCT20191106045356N5Yazd University of Medical Sciences48